Category Archives: Stem Cell Research

Ted Zhu - High School Stem Cell Research Intern - Summer 2013 Visit our Through Their Lens page for photos and more videos from students and grantees: http://www.cirm.ca.gov/instagram-CIRMStemCellLab-feed Ted Zhu is a W... By: California Institute for Regenerative Medicine … Continue reading →

Vanessa Yu - High School Stem Cell Research Intern - Summer 2013 Visit our Through Their Lens page for photos and more videos from students and grantees: http://www.cirm.ca.gov/instagram-CIRMStemCellLab-feed Vanessa Yu is ... By: California Institute for Regenerative Medicine … Continue reading →

Cambridge entrepreneur Jonathan Milner has launched a new, ethical stem cell business in the UKs technology capital and Axol Bioscience has shipped its maiden product just four months after startup. The company, which is tilting at a multibillion dollar global market, has a real ace to play as its product requires no testing on animals. Its first customer is the University of Cambridge. Neurobiology is one of the major sectors of biomedical research with an annual total public and private funding over $15 billion worldwide. Dr Shi said the current method of studying diseases of the nervous system involved the generation of animal models. However, genetically modifying animals to mimic human disease was extremely time consuming, expensive and ethically unsound, he said. Additionally, the models often failed to recapitulate the relevant human neuropathologies. A burning desire of many researchers is to study genuine human tissue samples however there are only very limited amounts of frozen postmortem brain tissue samples available for research, and using aborted foetal tissues for research is also ethically controversial. The Nobel Prize-winning cell reprogramming technology and proprietary neural tissue generation technology together provide an opportunity to derive an unlimited amount of patient-specific brain stem cells, which … Continue reading →

ANN ARBOR A new stem cell-based approach to studying epilepsy has yielded a surprising discovery about what causes one form of the disease, and may help in the search for better medicines to treat all kinds of seizure disorders. The findings, reported by a team of scientists from the University of Michigan Medical School and colleagues, use a technique that could be called epilepsy in a dish. By turning skin cells of epilepsy patients into stem cells, and then turning those stem cells into neurons, or brain nerve cells, the team created a miniature testing ground for epilepsy. They could even measure the signals that the cells were sending to one another, through tiny portals called sodium channels. In neurons derived from the cells of children who have a severe, rare genetic form of epilepsy called Dravet syndrome, the researchers report abnormally high levels of sodium current activity. They saw spontaneous bursts of communication and hyperexcitability that could potentially set off seizures. Neurons made from the skin cells of people without epilepsy showed none of this abnormal activity. They report their results online in the Annals of Neurology, and have further work in progress to create induced pluripotent stem cell … Continue reading →

Andrew Moreno - High School Stem Cell Research Intern - Summer 2013 This clip shows me weighing reagents for Xgal staining while I discuss some of the results I've gathered this summer. Visit our Through Their Lens page for p... By: California Institute for Regenerative Medicine … Continue reading →

DALLAS, Aug. 2, 2013 /PRNewswire-iReach/ -- This market research report explores the complex IP landscape affecting development of human embryonic stem cell products, providing clear guidance for companies entering or already within the market, from collaborating with WARF to less costly alternatives - such as circumventing the claims, conducting research off-shore, and developing embryonic stem cell products for other species. The report also gives you a wealth of valuable market data to ensure you develop and market products in this stem cell sector effectively. Understand historical and future growth projections, view competitive analysis of providers of hESC research tools and a breakdown of product categories. Learn this and much more in this leading 133-page market intelligence report "Opportunities in Human Embryonic Stem Cell Products" @ http://www.reportsnreports.com/reports/10600-opportunities-in-human-embryonic-stem-cell-hesc-products.html. This report will help you understand the market entry challenges you face and give you the expert advice to overcome the patent IP structure of the industry. Couple this with market leading intelligence data and this report is a must have if you're looking to outcompete your rivals in this expanding and highly profitable market. (Photo: http://photos.prnewswire.com/prnh/20130802/MN57791) The major reason for offering this report with up-to-date data and information is to guide biotechnology and … Continue reading →

Dr. Donald Kohn Discusses Stem Cell Research Breakthrough for Sickle Cell Disease Dr. Donald Kohn, researcher at the Eli Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and Jonsson Comprehensive Cancer Center ... By: UCLAJCCC … Continue reading →

I bring great news from the world of stem-cell research. Japanese scientists published a paper in the science journal Nature on July 3rd demonstrating proof of concept that a working human liver can be built in the laboratory from stem cells. The work was carried out by a team led by Takanori Takebe at Yokohama City University. This work is the first step in growing replacement livers from stem cells for transplants. There is a serious scarcity of livers for transplant. In 2011 more than 16,000 people in the US were on a waiting list for a liver transplant, 5,805 transplants were carried out and 2,938 people either died that year waiting for a new liver or became too ill to remain on the list. It will take about 10 years, all going well, to develop the initial work of Takebes team before livers grown from stem cells can be transplanted into humans. Im particularly pleased by Takebes work because this breakthrough was made using human-induced pluripotent stem cells (IPSC) and human adult stem cells derived from umbilical cords. No ethical problems necessarily attend the use of such stem cells unlike with human embryonic stem cells whose preparation entails killing … Continue reading →

CARLSBAD, CA--(Marketwired - Aug 1, 2013) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) a California-based biotechnology company developing novel stem cell based therapies and biomedical products announced today that it will host a conference call on Friday, August 9, 2013 to discuss its financial results for the three and six months ended June 30, 2013. Dr. Simon Craw, Executive Vice President and Mr. Jay Novak, Interim Chief Financial Officer of International Stem Cell will host the conference call. To attend the call, please use the dial in information below: Date: Friday, August 9, 2013 Time: 11:00 a.m. Eastern Time Conference Line (U.S.): 1-877-317-6776 International Dial-In: 1-412-317-6776 Conference ID: 10032411 Webcast: http://webcast.mzvaluemonitor.com/Cover.aspx?PlatformId=1545 Please dial in at least 10-minutes before the call to ensure timely participation. A playback of the call will be available until 11:00 a.m. ET on August 16, 2013. To listen, call 1-877-344-7529 within the United States or 1-412-317-0088 when calling internationally. Please use the replay pin number 10032411. About International Stem Cell Corporation International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the … Continue reading →

PARIS (Reuters) - France's top court approved a law on Thursday making it easier to conduct research on human embryos and stem cells as long as strict rules are followed to prevent cloning. Predominantly Roman Catholic France has until now had tough curbs on embryonic stem cell research under a 2011 law that only allows it with the explicit approval from the national biomedicine agency. Under a new law approved this month with majority backing from the governing Socialists and their allies, the agency's approval is no longer essential, although strict regulations must be followed to conduct such research in France. The Constitutional Council said it had approved the law, rejecting a last-ditch appeal by conservative lawmakers to get it thrown out. Stem cells are the body's mother cells and can self-renew or multiply while maintaining the ability to transform into any type of cell. Researchers around the world have been studying stem cells from various sources for more than a decade, hoping to capitalize on their ability to transform into a wide variety of other kinds of cell to treat a range of health conditions. View post: France’s top court approves stem cell research law … Continue reading →